By John Gruber
WorkOS: APIs to ship SSO, SCIM, FGA, and User Management in minutes. Check out their launch week.
Amy Goldstein and Scott Clement, reporting for The Washington Post:
Fewer than 1 in 4 Americans not yet immunized against the coronavirus say they would be willing to get the vaccine made by Johnson & Johnson, according to a Washington Post-ABC News poll that finds broad mistrust of the shot’s safety after federal health officials paused its use.
The nationwide survey shows that slightly fewer than half of U.S. adults overall say they consider the Johnson & Johnson vaccine very or somewhat safe after its use was halted this month following reports of rare, severe blood clots.
This is exactly why I’ve been so critical of the way the CDC and FDA handled this. They’ve trashed the reputation of an excellent vaccine over an extremely rare complication.
★ Monday, 26 April 2021